Preoperative Intravenous Iron to Treat Anaemia in Major Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

487

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Anaemia
Interventions
DRUG

Ferric carboxymaltose

1000mg of ferric carboxymaltose will be administered as an i.v. infusion (100ml normal saline)

DRUG

Normal saline

Normal saline will be administered as an i.v. infusion (100ml normal saline)

Trial Locations (28)

Unknown

Basildon University Hospital, Basildon

Blackpool Teaching Hospitals, Blackpool

Southmead Hospital, Bristol

Broomfield Hospital, Broomfield

Countess of Chester Hospital, Chester

Russells Hall Hospital, Dudley

Royal Infirmary of Edinburgh, Edinburgh

Queen Elizabeth Hospital, Gateshead

Hereford County Hospital, Hereford

Hillingdon Hospital, Hillingdon

St James's Hospital, Leeds

Aintree University Hospital, Liverpool

Liverpool Women's Hospital, Liverpool

Guy's and St Thomas' Hospital, London

Imperial College Hospital, London

King's College Hospital, London

Royal Marsden, London

James Cook University Hospital, Middlesbrough

Queen's Medical Centre, Nottingham

Pennine Acute Hospitals, Oldham

John Radcliffe Hospital, Oxford

Peterborough and Stamford Hospitals, Peterborough

Salford Royal, Salford

Northern General Hospital, Sheffield

Morriston Hospital, Swansea

Royal Cornwall Hospital, Truro

WC1E 6AU

University College London, London

SO16 6YD

Southampton General Hospital, Southampton

All Listed Sponsors
lead

University College, London

OTHER

NCT01692418 - Preoperative Intravenous Iron to Treat Anaemia in Major Surgery | Biotech Hunter | Biotech Hunter